International Journal of Molecular Sciences, 2026
Metabolism Pathway Blood Proteomic Differences in Lewy Body Dementia Compared to Alzheimer’s Disease

Pritha A., Chouliaras L., Swann P. et al.

Polish Archives of Internal Medicine, 2026
Association between plasma proteomic profiles and subclinical variations in left atrial strain in adults without overt cardiovascular disease: the role of cardiometabolic factors

Markowska M., Chlabicz M., Łaguna W. et al.

Allergy, 2026
Serum‐Proteomic Profiling Reveals Distinct Atopic Dermatitis Severity‐Linked Signatures

Lally J., Yoshida T., Gao S. et al.

Journal of Medical Virology, 2026
Associations of Inherited Chromosomally‐Integrated Human Herpesvirus 6 With Dementia Incidence, Inflammation, and Other Dementia Risk Factors in the UK Biobank

Qiya Z., Mandic M., Waterboer T. et al.

Nature Communications, 2026
Early life sugar rationing and ageing related diseases, biological ageing and mortality

Zheng J., Zhou Z., Huang J. et al.

Osteoarthritis and Cartilage Open, 2026
Movement smoothness and plasma proteomics are associated with functional impairment in knee osteoarthritis

Gawelowicz K., Simonsen M., Hedström M. et al.

PLOS One, 2026
The promise of deep urine proteomics for diagnosis of cancer, neurologic, and metabolic diseases

Budnik B., Amirkhani H., Weinberger K. et al.

The Oncologist, 2026
Phase 1/2 study of INCAGN01876, an anti-glucocorticoid-induced tumor necrosis factor receptor agonist monoclonal antibody, plus immunotherapy for advanced cancers

Hamid O., Forget F., Johnson M. et al.

Nature Aging, 2026
Plasma proteomics framework predicts metabolic dysfunction-associated steatotic liver disease up to 16 years before onset

Yu S., Chen C., Feng J. et al.

Biological Psychiatry Global Open Science, 2026
Smoking interacts with APOE ε4 to influence dementia: evidence from UK biobank and validation by meta-analysis of longitudinal studies

Cong Y., Wang Y., Huang L. et al.

Journal of Immunology Research, 2026
Cytokine Changes With Effective Drug Therapy for Juvenile Myasthenia Gravis

Geng Y., Liu P., Jin M. et al.

Nature Communications, 2026
A distinct CAR-T cell phenotype mediates therapeutic response at limited doses

Yousefian S., Schubert M., Minafra A. et al.

Science Translational Medicine, 2026
Robust CD4 ⁺ CAR T cell expansion is associated with non-ICANS neurotoxicities after ciltacabtagene autoleucel in patients with multiple myeloma

Jurgens E., Mitra S., Herrera K. et al.

American Journal of Nephrology, 2026
Galectin-9 as a circulating marker of mesangial injury and prognosis in biopsy-proven kidney disease

Tsai M., Li S., Kim D. et al.

International Journal of Antimicrobial Agents, 2026
An exploratory pharmacokinetic-pharmacodynamic analysis of ceftazidime-avibactam and various blood biomarkers in patients with hospital-acquired pneumonia or ventilator-associated pneumonia caused by Klebsiella pneumoniae

O’Jeanson A., Nielsen E., Athanassa Z. et al.

BMC Cancer, 2026
Exploration of plasma proteomic landscapes using Olink Reveal technology to identify biomarkers for early-stage/localized gastric cancer

Ding S., Li X., Dong X. et al.

Animal Models and Experimental Medicine, 2026
Age‐associated immune dysregulation links to disease severity in macrolide‐resistant Mycoplasma pneumoniae pneumonia: Insights from a comparative juvenile–adult mouse model

Li X., Wang Y., Liu L. et al.

Neurocritical Care, 2026
Mendelian Randomization Analysis of the IL-1 Cytokine Family Proteins Identifies IL1RL1 as a Potential Causal Contributor to Traumatic Brain Injury Prognosis

Bhak Y., Helmy A., Needham E. et al.

International Journal of Women's Health, 2026
Causal Effects of Circulating Inflammatory Proteins on Postmenopausal Atrophic Vaginitis in European Populations: A Mendelian Randomization Study with Transcriptomic Validation

Hu X., Ruan S., Zhong T. et al.

Molecular Psychiatry, 2026
Convergent neuroimmune signaling underlying rapid antidepressant response to ketamine and psychedelics

Jones G., Gilbert J., Johnston J. et al.